Skip to main content

Unintended Pregnancy

1
Pipeline Programs
5
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
4 programs
1
Family Planning InterventionPhase 2/31 trial
Jovenes SanosN/A1 trial
Pregnancy preferencesN/A1 trial
The Contraceptive Choice ProjectN/A1 trial
Active Trials
NCT03660514Completed124Est. Jan 2020
NCT03888404Active Not Recruiting2,015Est. Sep 2026
NCT01986439Unknown9,256Est. Dec 2016
+1 more trials
Tides Medical
Tides MedicalLA - Lafayette
1 program
Integrated family planning/HIV care and treatment servicesN/A1 trial
Active Trials
NCT01001507Completed5,040Est. Oct 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Human BioSciencesFamily Planning Intervention
Human BioSciencesPregnancy preferences
Human BioSciencesJovenes Sanos
Tides MedicalIntegrated family planning/HIV care and treatment services
Human BioSciencesThe Contraceptive Choice Project

Clinical Trials (5)

Total enrollment: 17,899 patients across 5 trials

NCT06923189Human BioSciencesFamily Planning Intervention

Efficacy Testing of a Multi-Level Family Planning Intervention

Start: Jun 2025Est. completion: Dec 20281,464 patients
Phase 2/3Recruiting
NCT03888404Human BioSciencesPregnancy preferences

Attitudes and Decision-making After Pregnancy Testing Study

Start: Mar 2019Est. completion: Sep 20262,015 patients
N/AActive Not Recruiting
NCT03660514Human BioSciencesJovenes Sanos

Jovenes Sanos: Preventing IPV and RC

Start: Sep 2018Est. completion: Jan 2020124 patients
N/ACompleted
NCT01001507Tides MedicalIntegrated family planning/HIV care and treatment services

Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya

Start: Sep 2009Est. completion: Oct 20115,040 patients
N/ACompleted
NCT01986439Human BioSciencesThe Contraceptive Choice Project

The Contraceptive Choice Project

Start: Aug 2007Est. completion: Dec 20169,256 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 17,899 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.